242 related articles for article (PubMed ID: 34541030)
1. Alterations in TGFβ signaling during prostate cancer progression.
Thompson-Elliott B; Johnson R; Khan SA
Am J Clin Exp Urol; 2021; 9(4):318-328. PubMed ID: 34541030
[TBL] [Abstract][Full Text] [Related]
2. JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.
Millena AC; Vo BT; Khan SA
J Biol Chem; 2016 Aug; 291(34):17964-76. PubMed ID: 27358408
[TBL] [Abstract][Full Text] [Related]
3. A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands.
Qin T; Barron L; Xia L; Huang H; Villarreal MM; Zwaagstra J; Collins C; Yang J; Zwieb C; Kodali R; Hinck CS; Kim SK; Reddick RL; Shu C; O'Connor-McCourt MD; Hinck AP; Sun LZ
Oncotarget; 2016 Dec; 7(52):86087-86102. PubMed ID: 27863384
[TBL] [Abstract][Full Text] [Related]
4. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
5. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of SnoN oncoprotein induced by antibiotics anisomycin and puromycin positively regulates transforming growth factor-β signals.
Hernández-Damián J; Tecalco-Cruz AC; Ríos-López DG; Vázquez-Victorio G; Vázquez-Macías A; Caligaris C; Sosa-Garrocho M; Flores-Pérez B; Romero-Avila M; Macías-Silva M
Biochim Biophys Acta; 2013 Nov; 1830(11):5049-58. PubMed ID: 23872350
[TBL] [Abstract][Full Text] [Related]
7. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
8. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
Kimbrough-Allah MN; Millena AC; Khan SA
Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
[TBL] [Abstract][Full Text] [Related]
9. SnoN suppresses TGF-β-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1γ-dependent manner.
Yin X; Xu C; Zheng X; Yuan H; Liu M; Qiu Y; Chen J
Oncol Rep; 2016 Sep; 36(3):1535-41. PubMed ID: 27430247
[TBL] [Abstract][Full Text] [Related]
10. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
[TBL] [Abstract][Full Text] [Related]
11. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
12. Verbascoside inhibits the epithelial-mesenchymal transition of prostate cancer cells through high-mobility group box 1/receptor for advanced glycation end-products/TGF-β pathway.
Wu CH; Chen CH; Hsieh PF; Lee YH; Kuo WW; Wu RC; Hung CH; Yang YL; Lin VC
Environ Toxicol; 2021 Jun; 36(6):1080-1089. PubMed ID: 33522686
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
Boone B; Haspeslagh M; Brochez L
J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
[TBL] [Abstract][Full Text] [Related]
14. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
15. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
16. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Hao Y; Baker D; Ten Dijke P
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
[TBL] [Abstract][Full Text] [Related]
17. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
[TBL] [Abstract][Full Text] [Related]
18. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
[TBL] [Abstract][Full Text] [Related]
19. The regulatory protein SnoN antagonizes activin/Smad2 protein signaling and thereby promotes adipocyte differentiation and obesity in mice.
Zhu Q; Chang A; Xu A; Luo K
J Biol Chem; 2018 Sep; 293(36):14100-14111. PubMed ID: 30030373
[TBL] [Abstract][Full Text] [Related]
20. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
